Answers are grounded in this paper and cite their sources.
Objective While drug‐eluting treatment is a first‐line therapy for femoropopliteal (FP) lesions, long‐term comparative data between drug‐eluting stents (DES) and drug‐coated balloons (DCB) in real‐world practice are scarce. We aimed to compare the 3‐year outcomes of DES versus DCB for symptomatic FP disease. Methods We conducted a retrospective analysis of the CILANTRO study, a multicenter registry combining data from the CAPSICUM, POPCORN, and POPCORN Type R studies. Patients treated with either DES or DCB for symptomatic FP lesions were included. To minimize selection bias, we performed 1:1 propensity score matching. The primary outcome was clinically driven target lesion revascularization (TLR), while secondary outcomes included restenosis. Results A total of 2651 patients treated with DCB and 972 with DES were identified. Propensity score matching extracted 912 pairs with well‐balanced baseline characteristics. The median follow‐up period was 31.6 months. The 3‐year rate of TLR was not significantly different between the DCB and DES groups (23.3% vs. 18.8%; hazard ratio, 1.19 [95% confidence interval, 0.93–1.53]; p = 0.16). Interaction analysis revealed that a more marked increased risk of TLR in the DCB group in patients with semi‐compliant balloon use or without non‐compliant balloon use ( p = 0.017 and 0.018). The 3‐year rate of restenosis was significantly higher in the DCB group than in the DES group (38.1% vs. 26.3%; hazard ratio, 1.77 [1.43–2.19]; p < 0.001). Conclusions In this propensity score‐matched analysis, the 3‐year rate of TLR was not significantly different between DCB and DES, although DES demonstrated lower restenosis rate. Nevertheless, DCB remains a clinically viable option, and our sub‐analysis suggests that balloon selection for pre‐dilatation may influence its efficacy.
No takes yet. Share an insight, caveat, or question.
Iida et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: